Literature DB >> 10630881

Chiral resolution of basic drugs by capillary electrophoresis with new glycosaminoglycans.

T Tsukamoto1, T Ushio, J Haginaka.   

Abstract

New glycosaminoglycans, fucose-containing glycosaminoglycan (FGAG) and depolymerized holothurian glycosaminoglycan (DHG), were investigated as chiral additives for the separation of drug enantiomers by capillary electrophoresis. The average molecular masses of FGAG and DHG were estimated to be about 59,000 and 14,000, respectively. A variety of basic drug enantiomers were resolved using 10 mM phosphate buffer, pH 5.0, containing 3% FGAG or DHG. Since chiral recognition properties of FGAG and DHG are different, some drug enantiomers were only separated by using FGAG or DHG. With regard to comparison of chiral recognition abilities of FGAG and DHG with other chiral selectors, tolperisone and eperisone enantiomers were not separated with alpha- or beta-cyclodextrin, or heparin as the chiral additives, but were separated with FGAG and DHG. The results obtained reveal that FGAG and DHG are useful as the chiral selectors for separations of drug enantiomers by CE, and that they could be complementarily used with other chiral additives.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10630881     DOI: 10.1016/s0021-9673(99)00969-3

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  3 in total

Review 1.  Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.

Authors:  Stefan Quasthoff; Claudia Möckel; Walter Zieglgänsberger; Wolfgang Schreibmayer
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

2.  Fucosylated chondroitin sulfate inhibits plasma thrombin generation via targeting of the factor IXa heparin-binding exosite.

Authors:  Yang Buyue; John P Sheehan
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113

Review 3.  Holothurian fucosylated chondroitin sulfate.

Authors:  Vitor H Pomin
Journal:  Mar Drugs       Date:  2014-01-09       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.